{"DataElement":{"publicId":"2954255","version":"1","preferredName":"Acute Myeloid Leukemia Disease Secondary Diagnosis Type","preferredDefinition":"the type of secondary cause for acute myeloid leukemia.","longName":"AML_DZ_SECNDRY_DX_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2954175","version":"1","preferredName":"Acute Myeloid Leukemia Disease Secondary Diagnosis","preferredDefinition":"information relating to a secondary (derived as a result of a primary condition) diagnosis (the investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms) and acute myeloid leukemia (AML; a clonal expansion of myeloid blasts in the bone marrow, blood or other tissues).","longName":"AML_DZ_SECNDRY_DX","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2593592","version":"1","preferredName":"Acute Myeloid Leukemia Diseases and Disorders","preferredDefinition":"A clonal expansion of myeloid blasts in the bone marrow, blood or other tissues.  The classification of acute myeloid leukemias (AMLs) encompasses four major categories: 1) AML with recurrent genetic abnormalities 2) AML with multilineage dysplasia 3) Therapy-related AML 4) AML not otherwise categorized.  The required bone marrow or peripheral blood blast percentage for the diagnosis of AML has been recently reduced from 30% (French-American-British [FAB] classification) to 20% (WHO classification).  (WHO, 2001) -- 2003:A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C3171:C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Myeloid Leukemia","conceptCode":"C3171","definition":"A clonal expansion of myeloid blasts in the bone marrow, blood or other tissues. The classification of acute myeloid leukemias (AMLs) encompasses four major categories: 1) AML with recurrent genetic abnormalities; 2) AML with multilineage dysplasia; 3) Therapy-related AML; 4) AML not otherwise specified. The required bone marrow or peripheral blood blast percentage for the diagnosis of AML is 20% (WHO classification).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28C10733-0450-3B22-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-05","modifiedBy":"ONEDATA","dateModified":"2007-02-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2954173","version":"1","preferredName":"Secondary Diagnosis","preferredDefinition":"Derived as a result of a primary condition; not direct or immediate; of second rank or importance or value.:The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","longName":"C25667:C15220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Secondary","conceptCode":"C25667","definition":"Derived as a result of a primary condition; not direct or immediate; of second rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"75FF3965-F2FC-E929-E040-BB89AD4306FB","latestVersionIndicator":"Yes","beginDate":"2009-10-15","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-10-15","modifiedBy":"ONEDATA","dateModified":"2009-10-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"75FF91A3-9A7F-1CC3-E040-BB89AD43153F","latestVersionIndicator":"Yes","beginDate":"2009-10-15","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-10-15","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2954249","version":"1","preferredName":"Secondary Diagnosis Type","preferredDefinition":"the type of secondary diagnosis.","longName":"SECNDRY_DX_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"70","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Prior treatment for other malignancy","valueDescription":"Prior treatment for other malignancy","ValueMeaning":{"publicId":"2954250","version":"1","preferredName":"Prior treatment for other malignancy","longName":"2954250","preferredDefinition":"Prior treatment for other malignancy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"760DD1F8-103B-0646-E040-BB89AD43575F","latestVersionIndicator":"Yes","beginDate":"2009-10-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-10-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"760DD1F8-1054-0646-E040-BB89AD43575F","beginDate":"2009-10-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-10-16","modifiedBy":"ONEDATA","dateModified":"2009-10-16","deletedIndicator":"No"},{"value":"Unexplained cytopenia","valueDescription":"Unexplained cytopenia","ValueMeaning":{"publicId":"2954251","version":"1","preferredName":"Unexplained cytopenia","longName":"2954251","preferredDefinition":"Unexplained cytopenia","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"760DD1F8-105E-0646-E040-BB89AD43575F","latestVersionIndicator":"Yes","beginDate":"2009-10-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-10-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"760DD1F8-1077-0646-E040-BB89AD43575F","beginDate":"2009-10-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-10-16","modifiedBy":"ONEDATA","dateModified":"2009-10-16","deletedIndicator":"No"},{"value":"Prior hematologic disorder (myeloproliferative disorders)","valueDescription":"Prior hematologic disorder (myeloproliferative disorders)","ValueMeaning":{"publicId":"2954252","version":"1","preferredName":"Prior hematologic disorder (myeloproliferative disorders)","longName":"2954252","preferredDefinition":"Prior hematologic disorder (myeloproliferative disorders)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"760DD1F8-1081-0646-E040-BB89AD43575F","latestVersionIndicator":"Yes","beginDate":"2009-10-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-10-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"760DD1F8-109A-0646-E040-BB89AD43575F","beginDate":"2009-10-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-10-16","modifiedBy":"ONEDATA","dateModified":"2009-10-16","deletedIndicator":"No"},{"value":"Prior hematologic disorder (MDS)","valueDescription":"Prior hematologic disorder (MDS)","ValueMeaning":{"publicId":"2954253","version":"1","preferredName":"Prior hematologic disorder (MDS)","longName":"2954253","preferredDefinition":"Prior hematologic disorder (MDS)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"760DD1F8-10A4-0646-E040-BB89AD43575F","latestVersionIndicator":"Yes","beginDate":"2009-10-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-10-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"760DD1F8-10BD-0646-E040-BB89AD43575F","beginDate":"2009-10-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-10-16","modifiedBy":"ONEDATA","dateModified":"2009-10-16","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"760DD1F8-1027-0646-E040-BB89AD43575F","latestVersionIndicator":"Yes","beginDate":"2009-10-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-10-16","modifiedBy":"SHIDED","dateModified":"2011-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811909","version":"1","longName":"Leukemia","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"If secondary, choose one","type":"Preferred Question Text","description":"If secondary, choose one","url":null,"context":"CTEP"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"760DD1F8-10C7-0646-E040-BB89AD43575F","latestVersionIndicator":"Yes","beginDate":"2009-10-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-10-16","modifiedBy":"CAMPBELB","dateModified":"2011-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}